Oropharyngeal Squamous Cell Carcinoma

general

A squamous cell carcinoma arising from the oropharynx. It predominantly affects adults in their fifth and sixth decades of life and is associated with alcohol and tobacco use. Human papillomavirus is present in approximately half of the cases. It is characterized by a tendency to metastasize early to the lymph nodes. When the tumor is small, patients are often asymptomatic. Physical examination may reveal erythematous or white lesions or plaques. The majority of patients present with locally adv

83

Centers

317

Active Trials

$3.5B

Cancer Funding

Specific Cancer Types(9)

Top Centers for Oropharyngeal Squamous Cell Carcinoma(83)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
80.8
2
NCI Comprehensive
High-Volume Research Center
77.3
3
NCI Comprehensive
High-Volume Research Center
76.8
4
High-Volume Research Center
76.3
569.6
6
NCI Comprehensive
Active Research Program
69.6
7
Active Research Program
63.6
8
NCI Comprehensive
Active Research Program
63.1
9
NCI Comprehensive
Active Research Program
62.1
10
NCI Comprehensive
Active Research Program
61.5
11
NCI Comprehensive
Active Research Program
61.5
12
NCI Comprehensive
Active Research Program
61.5
13
NCI Comprehensive
Active Research Program
61.5
14
NCI Comprehensive
Active Research Program
61.5
15
NCI Comprehensive
Active Research Program
61.5
16
NCI Comprehensive
Active Research Program
61.5
17
Active Research Program
61.5
18
Active Research Program
61.5
19
NCI Comprehensive
Active Research Program
61.5
20
NCI Comprehensive
Active Research Program
61.5
21
Active Research Program
61.5
22
NCI Comprehensive
Active Research Program
61.5
23
Active Research Program
61.5
24
NCI Comprehensive
Active Research Program
61.5
25
Active Research Program
61.5
26
Active Research Program
61.5
27
Active Research Program
61.5
28
Active Research Program
61.5
29
NCI Comprehensive
Active Research Program
50.6
30
NCI Comprehensive
Active Research Program
50.1
31
NCI Comprehensive
Active Research Program
48.1
32
NCI Comprehensive
Active Research Program
47.1
3346.6
34
NCI Comprehensive
Active Research Program
44.8
35
NCI Comprehensive
Active Research Program
44.8
36
NCI Comprehensive
Active Research Program
44.8
37
NCI Comprehensive
Active Research Program
44.8
38
NCI Comprehensive
Active Research Program
44.8
39
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
44.8
40
NCI Comprehensive
Active Research Program
44.8
41
NCI Comprehensive
Active Research Program
44.8
42
NCI Comprehensive
Active Research Program
44.8
43
NCI Comprehensive
Active Research Program
44.8
44
NCI Comprehensive
Active Research Program
44.8
45
NCI Comprehensive
Active Research Program
44.8
46
NCI Clinical
Active Research Program
44.8
47
NCI Comprehensive
Active Research Program
44.8
48
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
44.8
49
NCI Clinical
Active Research Program
44.8
50
NCI Comprehensive
Active Research Program
44.8
51
NCI Comprehensive
Active Research Program
44.8
52
NCI Clinical
Active Research Program
44.8
53
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
44.8
54
NCI Clinical
Active Research Program
44.8
55
Active Research Program
44.8
56
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
44.8
57
Active Research Program
44.8
58
Active Research Program
44.8
59
Active Research Program
44.8
60
NCI Comprehensive
30.4
61
NCI Comprehensive
30.4
62
NCI Comprehensive
30.4
63
NCI Comprehensive
30.4
6430.4
65
NCI Comprehensive
30.4
6630.4
6730.4
6830.4
6930.4
7030.4
71
NCI Comprehensive
72
73
74
75
NCI Comprehensive
76
NCI Clinical
77
78
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
79
NCI Basic_laboratory
80
81
82
83
BC CancerVancouver, BC

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →